AU2013240003B2 - Purification of cystathionine beta-synthase - Google Patents

Purification of cystathionine beta-synthase Download PDF

Info

Publication number
AU2013240003B2
AU2013240003B2 AU2013240003A AU2013240003A AU2013240003B2 AU 2013240003 B2 AU2013240003 B2 AU 2013240003B2 AU 2013240003 A AU2013240003 A AU 2013240003A AU 2013240003 A AU2013240003 A AU 2013240003A AU 2013240003 B2 AU2013240003 B2 AU 2013240003B2
Authority
AU
Australia
Prior art keywords
leu
gly
glu
ala
lys
Prior art date
Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
Active
Application number
AU2013240003A
Other languages
English (en)
Other versions
AU2013240003A1 (en
Inventor
Richard G. Carrillo
Jan P. Kraus
Tomas Majtan
David Naveh
Current Assignee (The listed assignees may be inaccurate. Google has not performed a legal analysis and makes no representation or warranty as to the accuracy of the list.)
University of Colorado Colorado Springs
Original Assignee
University of Colorado System
University of Colorado Colorado Springs
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by University of Colorado System, University of Colorado Colorado Springs filed Critical University of Colorado System
Publication of AU2013240003A1 publication Critical patent/AU2013240003A1/en
Application granted granted Critical
Publication of AU2013240003B2 publication Critical patent/AU2013240003B2/en
Assigned to THE REGENTS OF THE UNIVERSITY OF COLORADO, A BODY CORPORATE reassignment THE REGENTS OF THE UNIVERSITY OF COLORADO, A BODY CORPORATE Request to Amend Deed and Register Assignors: THE REGENTS OF THE UNIVERSITY OF COLORADO
Active legal-status Critical Current
Anticipated expiration legal-status Critical

Links

Classifications

    • C—CHEMISTRY; METALLURGY
    • C12—BIOCHEMISTRY; BEER; SPIRITS; WINE; VINEGAR; MICROBIOLOGY; ENZYMOLOGY; MUTATION OR GENETIC ENGINEERING
    • C12N—MICROORGANISMS OR ENZYMES; COMPOSITIONS THEREOF; PROPAGATING, PRESERVING, OR MAINTAINING MICROORGANISMS; MUTATION OR GENETIC ENGINEERING; CULTURE MEDIA
    • C12N9/00—Enzymes; Proenzymes; Compositions thereof; Processes for preparing, activating, inhibiting, separating or purifying enzymes
    • C12N9/88—Lyases (4.)
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K38/00—Medicinal preparations containing peptides
    • A61K38/16—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof
    • A61K38/43—Enzymes; Proenzymes; Derivatives thereof
    • A61K38/51—Lyases (4)
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P3/00—Drugs for disorders of the metabolism
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P43/00—Drugs for specific purposes, not provided for in groups A61P1/00-A61P41/00
    • B—PERFORMING OPERATIONS; TRANSPORTING
    • B01—PHYSICAL OR CHEMICAL PROCESSES OR APPARATUS IN GENERAL
    • B01D—SEPARATION
    • B01D15/00—Separating processes involving the treatment of liquids with solid sorbents; Apparatus therefor
    • B01D15/08—Selective adsorption, e.g. chromatography
    • B01D15/26—Selective adsorption, e.g. chromatography characterised by the separation mechanism
    • B01D15/36—Selective adsorption, e.g. chromatography characterised by the separation mechanism involving ionic interaction, e.g. ion-exchange, ion-pair, ion-suppression or ion-exclusion
    • B01D15/361—Ion-exchange
    • B01D15/363—Anion-exchange
    • B—PERFORMING OPERATIONS; TRANSPORTING
    • B01—PHYSICAL OR CHEMICAL PROCESSES OR APPARATUS IN GENERAL
    • B01D—SEPARATION
    • B01D15/00—Separating processes involving the treatment of liquids with solid sorbents; Apparatus therefor
    • B01D15/08—Selective adsorption, e.g. chromatography
    • B01D15/26—Selective adsorption, e.g. chromatography characterised by the separation mechanism
    • B01D15/38—Selective adsorption, e.g. chromatography characterised by the separation mechanism involving specific interaction not covered by one or more of groups B01D15/265 and B01D15/30 - B01D15/36, e.g. affinity, ligand exchange or chiral chromatography
    • B01D15/3804—Affinity chromatography
    • B01D15/3823—Affinity chromatography of other types, e.g. avidin, streptavidin or biotin
    • C—CHEMISTRY; METALLURGY
    • C12—BIOCHEMISTRY; BEER; SPIRITS; WINE; VINEGAR; MICROBIOLOGY; ENZYMOLOGY; MUTATION OR GENETIC ENGINEERING
    • C12Y—ENZYMES
    • C12Y402/00—Carbon-oxygen lyases (4.2)
    • C12Y402/01—Hydro-lyases (4.2.1)
    • C12Y402/01022—Cystathionine beta-synthase (4.2.1.22)
    • Y—GENERAL TAGGING OF NEW TECHNOLOGICAL DEVELOPMENTS; GENERAL TAGGING OF CROSS-SECTIONAL TECHNOLOGIES SPANNING OVER SEVERAL SECTIONS OF THE IPC; TECHNICAL SUBJECTS COVERED BY FORMER USPC CROSS-REFERENCE ART COLLECTIONS [XRACs] AND DIGESTS
    • Y02—TECHNOLOGIES OR APPLICATIONS FOR MITIGATION OR ADAPTATION AGAINST CLIMATE CHANGE
    • Y02A—TECHNOLOGIES FOR ADAPTATION TO CLIMATE CHANGE
    • Y02A50/00—TECHNOLOGIES FOR ADAPTATION TO CLIMATE CHANGE in human health protection, e.g. against extreme weather
    • Y02A50/30—Against vector-borne diseases, e.g. mosquito-borne, fly-borne, tick-borne or waterborne diseases whose impact is exacerbated by climate change

Landscapes

  • Chemical & Material Sciences (AREA)
  • Health & Medical Sciences (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Organic Chemistry (AREA)
  • Engineering & Computer Science (AREA)
  • Bioinformatics & Cheminformatics (AREA)
  • General Health & Medical Sciences (AREA)
  • Zoology (AREA)
  • Wood Science & Technology (AREA)
  • Genetics & Genomics (AREA)
  • Medicinal Chemistry (AREA)
  • Biochemistry (AREA)
  • General Engineering & Computer Science (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • Analytical Chemistry (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Veterinary Medicine (AREA)
  • Animal Behavior & Ethology (AREA)
  • Public Health (AREA)
  • Microbiology (AREA)
  • Molecular Biology (AREA)
  • Biotechnology (AREA)
  • Biomedical Technology (AREA)
  • Gastroenterology & Hepatology (AREA)
  • Immunology (AREA)
  • Proteomics, Peptides & Aminoacids (AREA)
  • Epidemiology (AREA)
  • Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
  • General Chemical & Material Sciences (AREA)
  • Obesity (AREA)
  • Diabetes (AREA)
  • Hematology (AREA)
  • Enzymes And Modification Thereof (AREA)
  • Peptides Or Proteins (AREA)
  • Preparation Of Compounds By Using Micro-Organisms (AREA)
  • Medicines That Contain Protein Lipid Enzymes And Other Medicines (AREA)
  • Micro-Organisms Or Cultivation Processes Thereof (AREA)
AU2013240003A 2012-03-26 2013-03-25 Purification of cystathionine beta-synthase Active AU2013240003B2 (en)

Applications Claiming Priority (5)

Application Number Priority Date Filing Date Title
US201261615629P 2012-03-26 2012-03-26
US61/615,629 2012-03-26
US13/830,494 2013-03-14
US13/830,494 US9243239B2 (en) 2012-03-26 2013-03-14 Purification of cystathionine beta-synthase
PCT/US2013/033716 WO2013148580A1 (en) 2012-03-26 2013-03-25 Purification of cystathionine beta-synthase

Publications (2)

Publication Number Publication Date
AU2013240003A1 AU2013240003A1 (en) 2014-10-02
AU2013240003B2 true AU2013240003B2 (en) 2018-04-19

Family

ID=49212017

Family Applications (1)

Application Number Title Priority Date Filing Date
AU2013240003A Active AU2013240003B2 (en) 2012-03-26 2013-03-25 Purification of cystathionine beta-synthase

Country Status (11)

Country Link
US (4) US9243239B2 (enExample)
EP (3) EP3569706A1 (enExample)
JP (3) JP6146934B2 (enExample)
CN (1) CN104540940B (enExample)
AU (1) AU2013240003B2 (enExample)
BR (1) BR112014023570B1 (enExample)
CA (1) CA2867719C (enExample)
HK (1) HK1246350B (enExample)
IL (2) IL234635B (enExample)
IN (1) IN2014DN07920A (enExample)
WO (1) WO2013148580A1 (enExample)

Families Citing this family (7)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US9034318B2 (en) 2011-08-30 2015-05-19 The Regents Of The University Of Colorado, A Body Corporate Chemically modified cystathionine beta-synthase enzyme for treatment of homocystinuria
US9243239B2 (en) 2012-03-26 2016-01-26 The Regents Of The University Of Colorado, A Body Corporate Purification of cystathionine beta-synthase
US9675678B2 (en) 2013-01-29 2017-06-13 The Regents Of The University Of Colorado, A Body Corporate Compositions and methods for treatment of homocystinuria
HRP20220407T1 (hr) 2015-11-09 2022-05-27 The Regents Of The University Of Colorado, A Body Corporate Pripravci i postupci za uporabu u liječenju homocistinurije
MX2019012347A (es) 2017-04-17 2020-01-15 Univ Colorado Regents Optimizacion de terapia de reemplazo enzimatico para el tratamiento de la homocistinuria.
WO2020264061A1 (en) * 2019-06-25 2020-12-30 Zymergen Inc. Engineered biosynthetic pathways for production of cystathionine by fermentation
FI3990005T3 (fi) 2019-06-26 2025-11-28 Travere Therapeutics Switzerland Gmbh Pegyloitu kystationiini-beta-syntaasi entsyymihoitoa varten homokystinurian hoitamiseksi

Citations (1)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
EP1878739A1 (en) * 2006-07-14 2008-01-16 LEK Pharmaceuticals D.D. One step IMAC (MCAC) purification of proteins

Family Cites Families (9)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
JPS5576559A (en) 1978-12-01 1980-06-09 Chiyou Lsi Gijutsu Kenkyu Kumiai Electron beam fine adjusting device
US5523225A (en) 1993-09-13 1996-06-04 Regents Of The University Of Colorado DNA sequence encoding human cystathionine β-synthase
US5635375A (en) 1995-01-09 1997-06-03 Regents Of The University Of Colorado Method of increasing the yield and heme saturation of cystathione β-synthase
AU2003251550A1 (en) 2002-06-17 2003-12-31 The Regents Of The University Of Colorado HUMAN CYSTATHIONINE Beta-SYNTHASE VARIANTS AND METHODS OF PRODU CTION THEREOF
GB0216001D0 (en) * 2002-07-10 2002-08-21 Nat Blood Authority Process and composition
EP1396537A1 (en) 2002-09-04 2004-03-10 Avidis SA Treatment of elevated plasma homocysteine
CN1552905A (zh) * 2003-12-18 2004-12-08 中国农业科学院茶叶研究所 一类茶树胱硫醚-γ-合成酶特异表达序列标签及其生物芯片
WO2011097381A2 (en) 2010-02-04 2011-08-11 The Board Of Regents Of Use University Of Texas System Engineered enzymes with methionine-gamma-lyase enzymes and pharmacological preparations therof
US9243239B2 (en) 2012-03-26 2016-01-26 The Regents Of The University Of Colorado, A Body Corporate Purification of cystathionine beta-synthase

Patent Citations (1)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
EP1878739A1 (en) * 2006-07-14 2008-01-16 LEK Pharmaceuticals D.D. One step IMAC (MCAC) purification of proteins

Non-Patent Citations (1)

* Cited by examiner, † Cited by third party
Title
BELEW M S ET AL, PROTEIN EXPRESSION AND PURIFICATION, 2009, vol. 64, pages 139 - 145 *

Also Published As

Publication number Publication date
US20160177287A1 (en) 2016-06-23
CN104540940B (zh) 2018-03-06
US20130251700A1 (en) 2013-09-26
CA2867719C (en) 2020-08-11
IL234635B (en) 2018-12-31
EP2831229B1 (en) 2017-10-18
US10160962B2 (en) 2018-12-25
EP3263701A1 (en) 2018-01-03
US20190055537A1 (en) 2019-02-21
JP6839595B2 (ja) 2021-03-10
EP2831229A1 (en) 2015-02-04
JP2017121255A (ja) 2017-07-13
WO2013148580A1 (en) 2013-10-03
JP2015512639A (ja) 2015-04-30
US9243239B2 (en) 2016-01-26
US20200131497A1 (en) 2020-04-30
HK1246350B (en) 2020-05-15
EP3263701B1 (en) 2019-06-19
AU2013240003A1 (en) 2014-10-02
EP2831229B8 (en) 2018-10-17
JP6146934B2 (ja) 2017-06-21
US10941392B2 (en) 2021-03-09
JP6952361B2 (ja) 2021-10-20
IL263162B (en) 2019-11-28
EP3569706A1 (en) 2019-11-20
BR112014023570B1 (pt) 2022-03-15
BR112014023570A2 (pt) 2021-06-01
IN2014DN07920A (enExample) 2015-05-01
CN104540940A (zh) 2015-04-22
IL263162A (en) 2018-12-31
JP2020000259A (ja) 2020-01-09
CA2867719A1 (en) 2013-10-03

Similar Documents

Publication Publication Date Title
JP6952361B2 (ja) シスタチオンβ−シンターゼの精製
HK1246350A1 (en) Purification of cystathionine beta-synthase
Mihara et al. cDNA cloning, purification, and characterization of mouse liver selenocysteine lyase: candidate for selenium delivery protein in selenoprotein synthesis
Kenny et al. Bacterial expression, purification, and characterization of rat kidney-type mitochondrial glutaminase
US10125353B2 (en) Recombinant therapeutic glycine N-acyltransferase
Yamada et al. An ectotherm homologue of human predicted gene NAT16 encodes histidine N-acetyltransferase responsible for Nα-acetylhistidine synthesis
HK40016298A (en) Purification of cystathionine beta-synthase
Board et al. Evidence against a relationship between fatty acid ethyl ester synthase and the Pi class glutathione S-transferase in humans
US20250340852A1 (en) Engineering new metabolic pathways in isolated cells for the degradation of guanidinoacetic acid and simultaneous production of creatine
Fadeeva et al. Highly active fractions of the medicinal leech recombinant destabilase-lysozyme
Lewis et al. Assembly of a Class I tRNA Synthetase from Products of an Artificially Split Genet

Legal Events

Date Code Title Description
DA3 Amendments made section 104

Free format text: THE NATURE OF THE AMENDMENT IS: AMEND THE NAME OF THE INVENTOR TO READ CARRILLO, RICHARD G.; KRAUS, JAN P.; MAJTAN, TOMAS AND NAVEH, DAVID

FGA Letters patent sealed or granted (standard patent)
HB Alteration of name in register

Owner name: THE REGENTS OF THE UNIVERSITY OF COLORADO, A BODY

Free format text: FORMER NAME(S): THE REGENTS OF THE UNIVERSITY OF COLORADO